MOLULOW
MSN to launch generic anti-COVID pill Molnupiravir under 'Molulow' brandThe group is all set to launch the generic Molnupiravir 200 mg capsules and it is being manufactured at its USFDA and MHRA accredited facil...
- Load More
One detail in a 248-year-old notebook changed everything for music historians
Centre plans Rs 12,000 crore incentive scheme to spur private electric bus adoption
NIA files charges against 11 over JMB offshoot's India terror expansion plot
The best seat on Earth for the 2026 total Solar Eclipse might be in this Spanish city
Mumbai's faith, food and identity: The battle over sacred traditions
India and Switzerland step up innovation partnership with focus on startups, research
Thousands join Ashura procession in Srinagar as Omar Abdullah, LG Sinha participate
Shelf-life norms for imported drugs may be relaxed to reduce wastage
ICAI to help Tirupati temple enhance accounting system
Goldman Sachs raises India FY27 growth forecast to 6.5%
El Nino may force India to boost rice-based ethanol output for E20 goal
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service